MayoComplete next-generation sequencing

Transforming comprehensive cancer care

Every person affected by cancer faces a unique journey shaped by their specific disease, clinical history, and preference for treatment. Ongoing, rapid advancements in cancer biomarker discovery and treatments, combined with the need for genetic testing to determine eligibility for certain therapies, require a dynamic testing approach that meets the needs of every patient.

Mayo Clinic Laboratories’ robust suite of MayoComplete oncology and hematology testing uses next-generation sequencing to identify and evaluate presence of mutations. Offering increased sensitivity and improved accuracy, our testing ensures health care providers understand the distinctive genetic features of their patients’ cancer to make informed decisions. MayoComplete next-generation sequencing:

  • Provides diagnostic, prognostic, and therapeutic insights, including the latest targeted immunotherapies.
  • Developed by and with expertise from Mayo Clinic geneticists, pathologists, oncologists, and hematologists to align with guidelines.
  • Designed to ensure each patient receives the right test and personalized answers to guide their cancer journey.

Learn more about how to order these tests at your institution.